These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 12905100)
21. Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists. Hamann J; Pfeiffer H; Leucht S; Kissling W Pharmacopsychiatry; 2003 Nov; 36(6):309-12. PubMed ID: 14663656 [TBL] [Abstract][Full Text] [Related]
22. Ethnic comparisons of antipsychotic use in schizophrenia. Wheeler A; Humberstone V; Robinson E Aust N Z J Psychiatry; 2008 Oct; 42(10):863-73. PubMed ID: 18777230 [TBL] [Abstract][Full Text] [Related]
23. Prescription patterns of patients diagnosed with schizophrenia in mental hospitals in Tashkent/Uzbekistan and in four German cities. Mundt AP; Aichberger MC; Fakhriddinov S; Fayzirahmanova M; Grohmann R; Heinz A; Ivens S; Magzumova S; Sartorius N; Ströhle A Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):145-51. PubMed ID: 21726013 [TBL] [Abstract][Full Text] [Related]
24. Sex differences in use of psychotropic drugs and drug-induced side effects in schizophrenia patients: findings of the Research on Asia Psychotropic Prescription (REAP) studies. Xiang YT; Wang CY; Si TM; Lee EH; He YL; Ungvari GS; Chiu HF; Yang SY; Chong MY; Shinfuku N; Tan CH; Kua EH; Fujii S; Sim K; Yong KH; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N Aust N Z J Psychiatry; 2011 Mar; 45(3):193-8. PubMed ID: 21142850 [TBL] [Abstract][Full Text] [Related]
25. Antipsychotic polypharmacy in patients with schizophrenia in a brief hospitalization unit. Lerma-Carrillo I; de Pablo Brühlmann S; del Pozo ML; Pascual-Pinazo F; Molina JD; Baca-García E Clin Neuropharmacol; 2008; 31(6):319-32. PubMed ID: 19050409 [TBL] [Abstract][Full Text] [Related]
26. Clinical and social determinants of psychotropic drug prescription for schizophrenia outpatients in China. Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS; Gerevich J Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):756-60. PubMed ID: 17289236 [TBL] [Abstract][Full Text] [Related]
27. Trends in antipsychotic prescribing practices in an urban community mental health clinic. Monshat K; Carty B; Olver J; Castle D; Bosanac P Australas Psychiatry; 2010 Jun; 18(3):238-41. PubMed ID: 20482426 [TBL] [Abstract][Full Text] [Related]
28. Antipsychotic polypharmacy in inpatients with schizophrenia in Asia (2001-2009). Xiang YT; Wang CY; Si TM; Lee EH; He YL; Ungvari GS; Chiu HF; Yang SY; Chong MY; Tan CH; Kua EH; Fujii S; Sim K; Yong KH; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Shinfuku N Pharmacopsychiatry; 2012 Jan; 45(1):7-12. PubMed ID: 21989602 [TBL] [Abstract][Full Text] [Related]
29. Combined treatment with amisulpride in patients with schizophrenia discharged from a short-term hospitalization unit: a 1-year retrospective study. Molina JD; Lerma-Carrillo I; Leonor M; Pascual F; Blasco-Fontecilla H; González-Parra S; López-Muñoz F; Alamo C Clin Neuropharmacol; 2009; 32(1):10-5. PubMed ID: 18978498 [TBL] [Abstract][Full Text] [Related]
30. Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009. Yoshio T; Inada T; Uno J; Miwa T; Kitagawa K; Miyahara Y; Umeda K; Kato T; Inagaki A; Nabeshima T Hum Psychopharmacol; 2012 Jan; 27(1):70-5. PubMed ID: 22249957 [TBL] [Abstract][Full Text] [Related]
31. Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison. Roh D; Chang JG; Kim CH; Cho HS; An SK; Jung YC Aust N Z J Psychiatry; 2014 Jan; 48(1):52-60. PubMed ID: 23671214 [TBL] [Abstract][Full Text] [Related]
32. [Polipharmacy in the antipsychotic prescribing in practices psychiatric out-patient clinic]. Florez Menéndez G; Blanco Ramos M; Gómez-Reino Rodríguez I; Gayoso Diz P; Bobes García J Actas Esp Psiquiatr; 2004; 32(6):333-9. PubMed ID: 15529221 [TBL] [Abstract][Full Text] [Related]
33. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003. Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060 [TBL] [Abstract][Full Text] [Related]
34. Why and how antipsychotic drugs are used in 40 Sydney nursing homes. Snowdon J; Day S; Baker W Int J Geriatr Psychiatry; 2005 Dec; 20(12):1146-52. PubMed ID: 16315158 [TBL] [Abstract][Full Text] [Related]
35. [A survey of drug utilization in psychiatric hospitals in Japan: the basic analysis of the current status of prescription patterns]. Yamauchi K; Baba K; Ikegami N; Miyaoka H; Kamijima K Seishin Shinkeigaku Zasshi; 1998; 100(1):51-68. PubMed ID: 9557543 [TBL] [Abstract][Full Text] [Related]
36. Effects of age and age of onset on prescribed antipsychotic dose in schizophrenia spectrum disorders: a survey of 1,418 patients in Japan. Uchida H; Suzuki T; Mamo DC; Mulsant BH; Tanabe A; Inagaki A; Watanabe K; Yagi G; Tomita M Am J Geriatr Psychiatry; 2008 Jul; 16(7):584-93. PubMed ID: 18591578 [TBL] [Abstract][Full Text] [Related]
37. Predictors for starting depot administration of risperidone in chronic users of antipsychotics. Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430 [TBL] [Abstract][Full Text] [Related]
38. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165 [TBL] [Abstract][Full Text] [Related]
39. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia. Loosbrock DL; Zhao Z; Johnstone BM; Morris LS J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539 [TBL] [Abstract][Full Text] [Related]
40. [Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit]. Armand-Branger S; Poisson N; Gaudoneix-Taïeb M; Ramos O Encephale; 2009 Sep; 35(4):370-6. PubMed ID: 19748374 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]